Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
SPRY ARS Pharmaceuticals
- 14.015
- +0.245+1.78%
Trading Apr 28 11:42 ET
1.38BMarket Cap175.19P/E (TTM)
14.270High13.845Low356.69KVolume13.890Open13.770Pre Close5.00MTurnover0.77%Turnover Ratio175.19P/E (Static)98.12MShares18.51052wk High5.36P/B651.99MFloat Cap7.55052wk Low--Dividend TTM46.52MShs Float63.410Historical High--Div YieldTTM3.09%Amplitude2.550Historical Low14.022Avg Price1Lot Size
About ARS Pharmaceuticals Company
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.
Company Profile
SymbolSPRY
Company NameARS Pharmaceuticals
Listing DateDec 4, 2020
Founded2015
CEOMr. Richard E. Lowenthal, M.B.A.,M.S.
MarketNASDAQ
Employees160
Fiscal Year Ends12-31
Address11682 El Camino Real,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-206-456-2900
Websitehttp://www.ars-pharma.com
Company Executives
- Name
- Position
- Salary
- Richard E. Lowenthal, M.B.A.,M.S.
- President, Chief Executive Officer and Director
- 10.04M
- Kathleen D. Scott
- Chief Financial Officer and Principal Accounting Officer
- --
- Justin Chakma
- Chief Business Officer
- --
- Eric Karas
- Chief Commercial Officer
- --
- Brian T. Dorsey
- Chief Operating Officer
- --
- Alexander A. Fitzpatrick
- Chief Legal Officer and Secretary
- 5.32M
- Dr. Sarina Tanimoto, M.B.A.,M.D.
- Chief Medical Officer
- --
- Dr. Pratik Shah, PhD
- Chairman of the Board
- 508.80K
- Brenton L. Saunders
- Director
- 238.80K
- Dr. Laura Shawver, PhD
- Director
- 238.80K
- Saqib Islam, J.D.
- Independent Director
- 250.05K
- Phillip M. Schneider
- Independent Director
- 261.30K
- Michael Kelly
- Independent Director
- 248.80K
- Dr. Rajeev Dadoo, PhD
- Independent Director
- 256.30K
- Dr. Peter Kolchinsky, PhD
- Independent Director
- 253.80K
- Dr. Peter A. Thompson,M.D.,F.A.C.P.
- Independent Director
- 242.55K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
